HIV暴露后预防

[1] Emergency department management of occupational exposures: cost analysis of rapid HIV test. Kallenborn JC, Price TG, Carrico R, et al. Infection Control and Hospital Epidemiology . 2001

[2] Post-exposure prophylaxis for non-occupational exposure to HIV: Current clinical practice and opinions in the UK. Giele CM, Maw R, Carne CA, et al. Sexually Transmitted Infections . 2002

[3] experience of healthcare workers talking postexposure prophylaxis after occupational HIV exposure: findings of the HIV Postexposure Prophylaxis Registry. Wang SA, panlilio AL, Doi PA, et al. Infection Control and Hospital Epidemiology . 2000

[4] Postexposure prophylixis for human immunodeficiency ivrus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure. Roland ME, Martin JN, Grant RM, et al. The Journal of Infectious Diseases . 2001

[5] Occupational exposure to HIV in health care settings. Julie Louise Gerberding. The New England Journal of Medicine . 2003

[6] Postexposure treatent of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. Katz MH, Gerberding JL. The New England Journal of Medicine . 1997

[7] AIDS [J]. 2001, American Chemical Society (79)

[8] Effectiveness of postinoculation（R）-9-（ 2-phosphonylmethoxypropyl） adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. Tsai C-C, Emau P, Follis KE, et al. Journal of Virology . 1998

[9] A case - control study of HIV seroconversion in health care workers after percutaneous exposure. Cardo DM, Culver DH, Ciesielski CA, et al. The New England Journal of Medicine . 1997

[10] Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Busch M, Lee LL, Satten GA, et al. Transfusion . 1995

[1] Emergency department management of occupational exposures: cost analysis of rapid HIV test. Kallenborn JC, Price TG, Carrico R, et al. Infection Control and Hospital Epidemiology . 2001

[2] Post-exposure prophylaxis for non-occupational exposure to HIV: Current clinical practice and opinions in the UK. Giele CM, Maw R, Carne CA, et al. Sexually Transmitted Infections . 2002

[3] experience of healthcare workers talking postexposure prophylaxis after occupational HIV exposure: findings of the HIV Postexposure Prophylaxis Registry. Wang SA, panlilio AL, Doi PA, et al. Infection Control and Hospital Epidemiology . 2000

[4] Postexposure prophylixis for human immunodeficiency ivrus infection after sexual or injection drug use exposure: identification and characterization of the source of exposure. Roland ME, Martin JN, Grant RM, et al. The Journal of Infectious Diseases . 2001

[5] Occupational exposure to HIV in health care settings. Julie Louise Gerberding. The New England Journal of Medicine . 2003

[6] Postexposure treatent of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. Katz MH, Gerberding JL. The New England Journal of Medicine . 1997

[7] AIDS [J]. 2001, American Chemical Society (79)

[8] Effectiveness of postinoculation（R）-9-（ 2-phosphonylmethoxypropyl） adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. Tsai C-C, Emau P, Follis KE, et al. Journal of Virology . 1998

[9] A case - control study of HIV seroconversion in health care workers after percutaneous exposure. Cardo DM, Culver DH, Ciesielski CA, et al. The New England Journal of Medicine . 1997

[10] Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Busch M, Lee LL, Satten GA, et al. Transfusion . 1995